首页> 外文期刊>Frontiers in Chemistry >DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors
【24h】

DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors

机译:对生长抑素sst2,5受体具有高亲和力的奥曲肽双氨基甲酸酯的DOTA衍生物

获取原文
           

摘要

In vivo somatostatin receptor scintigraphy is a valuable method for the visualization of human endocrine tumours and their metastases. In fact, peptide ligands of somatostatin receptors (sst’s) conjugated with chelating agents are in clinical use. We have recently developed octreotide dicarba-analogues, which show interesting binding profiles at sst’s. In this context, it was mandatory to explore the possibility that our analogues could maintain their activity also upon conjugation with DOTA. In this paper, we report and discuss the synthesis, binding affinity and conformational preferences of three DOTA-conjugated dicarba-analogues of octreotide. Interestingly, two conjugated analogues exhibited nanomolar affinities on sst2 and sst5 somatostatin receptor subtypes.
机译:体内生长抑素受体闪烁显像是一种可视化人内分泌肿瘤及其转移的有价值的方法。实际上,与螯合剂结合的生长抑素受体(sst's)的肽配体正在临床中使用。我们最近开发出了奥曲肽二卡巴类似物,该化合物在sst处显示出有趣的结合特征。在这种情况下,必须探索与DOTA结合后我们的类似物也可以维持其活性的可能性。在本文中,我们报告并讨论了三种奥曲肽的DOTA共轭双氨基甲酸酯类似物的合成,结合亲和力和构象偏好。有趣的是,两个共轭类似物在sst2和sst5生长抑素受体亚型上表现出纳摩尔亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号